Mangoceuticals gets Nasdaq extension to regain $1 minimum bid price compliance by Feb. 1, 2027
Reuters2026/08/04 20:37- Mangoceuticals received a 180-day Nasdaq extension to regain compliance with the $1 minimum bid price rule.
- The deadline to meet the requirement is Feb. 1, 2027, with compliance defined as at least 10 consecutive business days at $1 or higher.
- The company signaled it may use a reverse stock split to cure the deficiency within the extension period.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NVE Director Daniel A. Baker disposes of 21,140 shares worth $2.15 million
CleanSpark CTO, COO Taylor Monnig disposes of USD 1.83 million in common shares
Bank of America: Nvidia and Broadcom have the widest holdings, with Micron and AMD significantly added by actively managed funds
Bank of America stated that among active fund managers in the United States, Nvidia and Broadcom hold the "widest" position base in the semiconductor sector, while the holding proportions of Micron Technology and AMD have also seen significant increases.
Terawulf director Catherine J. Motz disposes of 56,023 common shares worth USD 997,976.18
Crypto prices
More
